Pharmaceutical companies in Philadelphia: a suburban, high-wage market across three states

Use this report if you're looking for drugmakers around Philadelphia to work for, supply or sell to. It follows the Census Bureau's metro area, which takes in five Pennsylvania counties, four in South Jersey, New Castle County in Delaware and Cecil County in Maryland, so it includes Wilmington and Camden.

Where the jobs are

County Business Patterns (CBP) 2023, NAICS 3254 (Pharmaceutical and Medicine Manufacturing):

Montgomery County has 53% of the metro's jobs in the industry. "Not reported" means the Census Bureau published the figure but flagged it as high-noise: the noise it adds to protect confidentiality moved the value by 5% or more. Bucks County shows the opposite pattern to Montgomery, with 12 sites averaging about 30 employees.

The metro totals

Philadelphia-Camden-Wilmington, PA-NJ-DE-MD Metro Area (CBSA 37980):

The Census Bureau doesn't publish the 500 to 999 or 1,000 or more cells for this metro; the 3 is the total less the published classes. Within the first row, 15 establishments have 1 to 4 employees, 10 have 5 to 9 and 10 have 10 to 19.

By six-digit code, 44 establishments make finished dose pharmaceuticals (325412, 4,271 employees), 25 make biologics such as vaccines, blood fractions and gene therapy preparations (325414), 7 make in-vitro diagnostic substances and 7 make medicinal chemicals. The biologics and diagnostics employee totals are high-noise figures.

CBP's unit is the establishment with paid employees, not the company, and it leaves out sole proprietors without staff. NAICS 3254 also leaves out most research and corporate work. The same data shows 196 biotechnology R&D establishments in the metro (NAICS 541714) with 8,001 employees, more than twice as many locations as the plants, and 177 drug wholesale establishments (NAICS 424210), whose employee total is a high-noise figure.

What FDA's registration file shows

FDA's Drug Establishments Current Registration Site (DECRS) lists sites that manufacture, prepare, propagate, compound or process drugs for the US market, updated each business day. Our count of the download on 30 October 2026, by the metro's counties:

Philadelphia has the most registrations (18), then Malvern (8), Horsham (7) and Wilmington (6). Registrants include Merck Sharp & Dohme (West Point), GlaxoSmithKline (Conshohocken), Janssen Biotech (Malvern), AstraZeneca Pharmaceuticals (Newark, Delaware, and Philadelphia), Spark Therapeutics (Philadelphia), Almac Pharma Services (Audubon), Endo USA (Horsham), Kenvue Brands (Fort Washington) and Siegfried USA (Pennsville, New Jersey). Merck's 10-K adds that it keeps divisional headquarters in Upper Gwynedd and a principal US research facility at West Point. None of these registrations is an FDA approval; companies file them.

Listed drugmakers headquartered in the metro

SEC EDGAR shows 21 listed companies in SIC codes 2833 to 2836 with a business address in the metro. Most are clinical-stage. Checked in each latest 10-K ("none reported" means the company had no product or other revenue):

Others with clinical programs and addresses in the metro include Larimar Therapeutics (Bala Cynwyd), Context Therapeutics (Philadelphia), Palvella Therapeutics and Avalo Therapeutics (Wayne) and Annovis Bio (Malvern). At a company of 20 to 150 people, one technical operations leader usually decides outsourced manufacturing and testing, so find that person first.

One market, three regulators

The agencies are those FDA lists for checking wholesale distributor and third-party logistics licences. For any site, also read FDA's Data Dashboard for inspections, warning letters and recalls before you sign a supply or quality agreement. To meet the companies, Life Sciences PA, the state's industry association, publishes a member directory.

Selling into the Philadelphia market

Worked example: a specialty courier

Illustrative example. The courier and its rates are invented; the counts come from CBP 2023 and FDA's registration file.

Schuylkill Cold Chain (schuylkillcold.example) moves temperature-controlled samples and clinical material between labs, plants and trial sites.

1. Build the list. 196 biotechnology R&D establishments plus 86 manufacturing registrations that aren't gas suppliers: 282 locations, some belonging to the same companies.
2. Prioritize. Start with Montgomery, Chester and New Castle counties, where the registrations and the larger plants cluster.
3. Do the arithmetic. Reaching a shipping or clinical supply lead at 40% of 282 gives 113 conversations. If 10% lead to a trial shipment, that's 11, and if 3 become accounts at $45,000 a year, $135,000.

The research to find each site's shipping owner is the slow part; Bebop researches each account in a list and suggests the person to contact and the angle to open with.

Hi [first name], I saw [company] opened [a new trial, a lab move, a site] in [town]. Teams in that position often tell us their courier is fine for routine runs but not for same-day, temperature-controlled moves across the river. We do those between Philadelphia-area labs and sites every day. Worth a short call to compare notes on your next shipment?

For the global ranking of the companies with sites here, see the largest pharmaceutical companies.

Next step: cross the river with the New Jersey pharmaceutical market report.